Andrew McDonough

Mr. McDonough has served clients in matters involving a broad range of technologies, including pharmaceutical sciences, genetically modified crops, and light-emitting diode (LED) manufacturing. His experience includes working on a range of intellectual property matters, such as Hatch-Waxman or ANDA litigation, other district court patent litigation, and appeals before the Federal Circuit. Mr. McDonough has been involved in all phases of patent litigation, from pre-suit investigations through trial and appeal.

Mr. McDonough’s recent experience and engagements include:

• Co-authored successful motion to strike untimely patent infringement theory in federal District of Delaware ANDA litigation.
• Representing generic pharmaceutical manufacturers in patent infringement litigation under the Hatch-Waxman Act.
• Representing a foreign governmental entity in an appeal before the Federal Circuit which involves infringement of a patent on methods of genetically modifying crops.
• Representing multinational lighting manufacturer in patent infringement litigation before the U.S. International Trade Commission.
• Represented Harvard University in suits in federal and state court alleging violations of Title IX and the Massachusetts Civil Rights Act.
• Co-authored briefs on behalf of an indigent tenant whose eviction and dispossession was held to be “not consonant with principles of due process.” See Glendale Associates, LP v. Harris, 148 N.E. 3d 1226, 97 Mass. App. Ct. 454 (2020).